Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease

<div>Study endpoints at 12 months. MACE: major adverse cardiac events; MI: myocardial infarction; TLF: target lesion failure; TLR: target lesion revascularization; TVMI: target vessel myocardial infarction; TVR: target vessel revascularization.</div>

Journal of Interventional Cardiology

fig2

Figure 2

Figure 2: Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease 